ClinicalTrials.gov
ClinicalTrials.gov Menu

Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01310946
Recruitment Status : Unknown
Verified December 2011 by King Faisal Specialist Hospital & Research Center.
Recruitment status was:  Recruiting
First Posted : March 9, 2011
Last Update Posted : December 13, 2011
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center

Brief Summary:
Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

Condition or disease Intervention/treatment
Acute Lymphocytic Leukemia Other: Database

Detailed Description:
Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

Study Type : Observational
Estimated Enrollment : 203 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology
Study Start Date : June 2003



Intervention Details:
    Other: Database
    Database



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   14 Years to 85 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Acute Lymphocytic Leukemia Database
Criteria

Inclusion Criteria:

  • Patients with diagnosed Acute Lymphocytic Leukemia

Exclusion Criteria:

  • Patients with diagnosis other than Acute Lymphocytic Leukemia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01310946


Contacts
Contact: N Chaudhri, M.D. +966-1-4423949

Locations
Saudi Arabia
Kfsh & Rc Recruiting
Riyadh, Saudi Arabia
Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: N Chaudhri, M.D. KFSH & RC

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT01310946     History of Changes
Other Study ID Numbers: RAC# 2021-051
RAC# 2021-051 ( Other Identifier: KFSH&RC )
First Posted: March 9, 2011    Key Record Dates
Last Update Posted: December 13, 2011
Last Verified: December 2011

Keywords provided by King Faisal Specialist Hospital & Research Center:
Acute Lymphocytic Leukemia

Additional relevant MeSH terms:
Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases